PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
07-Apr-2022 Heidelberg Pharma to Present New Data on its Proprietary ATAC(R) Technology Platform at the AACR Annual Meeting 2022 Heidelberg Pharma AG
07-Apr-2022 PharmaZell and Novasep announce the creation of a leading CDMO and API manufacturer PharmaZell
07-Apr-2022 Hansa Biopharma publishes Annual Report 2021 Hansa Biopharma
07-Apr-2022 Kynos Therapeutics Emerges from Stealth with £9 Million Financing and Phase 1-ready KMO Inhibitor Kynos Therapeutics
07-Apr-2022 Faller Packaging together with partner Rotzinger at Pharmapack Faller Packaging
07-Apr-2022 Novo Holdings Portfolio Company ReViral to be Acquired by Pfizer Novo Holdings A/S
07-Apr-2022 Midlands Engine partners share groundbreaking Blueprint to tackle diabetes rates and health inequalities across the region and country Midlands Engine
07-Apr-2022 ISCT announces recipients of key 2022 achievement awards in cell and gene therapy The International Society for Cell and Gene Therapy (ISCT)
07-Apr-2022 Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates Sciad Newswire
07-Apr-2022 Elekta and GE Healthcare collaborate to expand access to precision radiation therapy solutions Elekta
07-Apr-2022 Dupixent® (dupilumab) approved by European Commission for children aged 6 to 11 years with severe asthma with type 2 inflammation Sanofi
07-Apr-2022 iOmx to Present New Pre-Clinical Data on SIK3 Checkpoint Inhibitor OMX-0407 at AACR 2022 iOmx Therapeutics AG
07-Apr-2022 BioXcel Therapeutics Announces FDA Approval of IGALMIā„¢ (dexmedetomidine) Sublingual Film for Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I or II Disorder in Adults BioXcel Therapeutics
07-Apr-2022 DEFENCE THERAPEUTICS ANNOUNCES ISSUANCE OF A U.S. PATENT COVERING ITS PIONEERING VACCINE PLATFORM TECHNOLOGY Defence Therapeutics Inc.
07-Apr-2022 Biophytis provides updates on Sarconeos (BIO101) clinical development Biophytis
07-Apr-2022 Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives Biophytis
07-Apr-2022 Biotest AG: Biotest submits marketing authorisation application for IgG Next Generation and signed first licensing agreement Biotest AG
07-Apr-2022 AEVIS VICTORIA SA - Ordinary General Meeting of Shareholders on 28 April 2022 AEVIS VICTORIA SA
07-Apr-2022 Gerresheimer AG: Gerresheimer raises revenue guidance for 2022 to double-digit growth after strong first quarter Gerresheimer AG
06-Apr-2022 FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA SMi Group